AEG and City of Hope

City of Hope is a biomedical research, treatment and education center dedicated to the prevention, treatment and cure of cancer and other life-threatening diseases. Our mission is to shorten the time from initial research idea to new treatment, quickly bringing cures to patients who need them.

Since its founding in 1913, City of Hope has achieved numerous scientific breakthroughs and pioneered many lifesaving procedures that have impacted treatment worldwide.

Here are the latest facts about this institution.

City of Hope is one of 41 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.

City of Hope is a founding member of the National Comprehensive Cancer Network, an alliance of the 21 leading cancer centers that defines and sets standards for cancer care nationally.

City of Hope maintains the No. 1 hematology program, No. 1 prostate cancer program and No. 1 sarcoma program in California and ranks No. 2 in the state for its breast cancer and musculoskeletal programs, based on the number of patients treated. (Source: Office of Statewide Health Planning and Development)

City of Hope has been designated an islet cell transplant center by the Juvenile Diabetes Research Foundation (JDRF), one of only 14 institutions in the United States to receive this distinction. JDRF islet cell transplant centers are programs at select institutions that enable scientists and clinicians to collaborate and transform new ideas into treatments.

At any given time, City of Hope conducts more than 300 clinical studies, involving 30 to 40 percent of its eligible patients. The national average is less than 5 percent.

City of Hope was awarded more than $59 million in research grants and received nearly $170 million in revenues from patented technologies in FY2008.